Breathe Well Live Well
| Related Articles |
Can we prevent Childhood Asthma Before Birth?: Summary of the VDAART results so far.
Expert Rev Respir Med. 2016 Aug 26;
Authors: Weiss ST, Litonjua AA
PMID: 27564842 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Wall Street Journal |
AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by … AstraZeneca set to go head to head against GSK with asthma drug AstraZeneca asthma drug hits goal, to enter competitive market AstraZeneca's asthma biologic hits PhIII target, but still behind rivals |
View full post on asthma – Google News
Reuters |
AstraZeneca Asthma Drug Shows Positive Results
Wall Street Journal Bing Yao, head of respiratory medicine at the company's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in severe asthma patients. He said the Glaxo and Teva drugs, by contrast, act indirectly by … AstraZeneca asthma drug hits goal, to enter competitive market AstraZeneca climbs after positive asthma treatment results AstraZeneca: Asthma drug trial results positive |
View full post on asthma – Google News
Reuters |
AstraZeneca boosted by good results for biotech asthma drug
Reuters LONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously flagged as a potential $2 billion-a-year product. AstraZeneca: Asthma drug trial results positive Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe Asthma TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial Results |
View full post on asthma – Google News
Reuters UK |
AstraZeneca: Asthma drug trial results positive
MarketWatch LONDON–AstraZeneca PLC (AZN.LN) said Tuesday its potential new medicine benralizumab showed positive results in a Phase III trial for asthma treatment. The treatment "was well tolerated and achieved the primary endpoint in two pivotal Phase III … AstraZeneca boosted by good results for biotech asthma drug Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe Asthma TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial Results |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX® Asthma …
GlobeNewswire (press release) The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function. The trial demonstrated that GRAZAX® treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma … BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in children ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma … |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma …
EconoTimes In contrast, treatment with GRAZAX(r) had a positive effect on the children's asthma symptoms and use of asthma medication. The odds ratio (secondary endpoint) for experiencing asthma symptoms[1] or using asthma medication[2], at the end of the five … |
View full post on asthma – Google News
| Related Articles |
ERJ November Podcast: results from the adult and paediatric cohorts of the U-BIOPRED study of severe asthma.
Eur Respir J. 2015 Nov;46(5):E59
Authors:
PMID: 26521291 [PubMed – in process]
View full post on pubmed: asthma
Fox News |
Researchers 'delighted' with results of iPhone Asthma Health app
Fox News “We are delighted with the initial results we've seen after six months of using Apple's ResearchKit framework for our Asthma Health app,” said Eric Schadt, professor of genomics at the Icahn School of Medicine, in a press release. “We recruited and … |
View full post on asthma – Google News
|
Mount Sinai and LifeMap Solutions announce initial results for asthma health app
Medical Xpress The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a digital-health subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced initial results and new clinical features for their free Asthma Health app. Released six months ago, the … Asthma app moves from research to reality Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health … |
View full post on asthma – Google News